CC
AVNS

Cannell & Co’s Avanos Medical AVNS Stock Holding History

Cannell & Co’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-16,826
Closed -$583K – 251
2016
Q3 		$583K Sell
16,826
-219
-1% -$7.67K 0.02% 196
2016
Q2 		$554K Hold
17,045
– – 0.02% 200
2016
Q1 		$490K Sell
17,045
-2,500
-13% -$66.6K 0.02% 205
2015
Q4 		$653K Sell
19,545
-2,562
-12% -$79.7K 0.02% 194
2015
Q3 		$629K Sell
22,107
-1,994
-8% -$69.6K 0.02% 200
2015
Q2 		$976K Buy
24,101
+851
+4% +$38.2K 0.03% 173
2015
Q1 		$1.14M Buy
23,250
+640
+3% +$29.6K 0.03% 169
2014
Q4 		$1.03M Buy
+22,610
New +$888K 0.03% 171

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Cannell & Co's AVNS Position: Q4 2016 in Review

Cannell & Co sold out of Avanos Medical (AVNS) in Q4 2016, closing a stake of 16,826 shares — an estimated $583K sold.

Cannell & Co first reported a position in AVNS in Q4 2014 and held it in 8 quarters. The position peaked at $1.14M in Q1 2015. 360 funds tracked by Wall St. Rank hold AVNS as of Q4 2016.

  • Cannell & Co reported no remaining Avanos Medical position as of Q4 2016 after selling out during the quarter.
  • Cannell & Co sold 16,826 Avanos Medical shares in Q4 2016, an estimated $583K.
  • Cannell & Co first reported a position in Avanos Medical in Q4 2014 and held it in 8 quarters.
  • Cannell & Co's Avanos Medical position peaked at $1.14M in Q1 2015.
  • 360 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2016.

Based on Cannell & Co's 13F filing for Q4 2016, filed 13 Feb 2017.